US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 3.800
  • -0.070-1.81%
Close Apr 26 16:00 ET
  • 3.880
  • +0.080+2.11%
Post 17:42 ET
432.38MMarket Cap-2317P/E (TTM)

Fate Therapeutics Key Stats

Fate Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 26, 2024

Revenue(YoY)

1.68M

-96.22%
EPS(YoY)

-0.45

+22.41%

Hold

Apr 12, 2024

Fate Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.273M--
--2024/Q1-- / 1.260M--
Feb 26, 20242023/Q41.676M / 1.528M--
Nov 8, 20232023/Q31.944M / 900.000K--
Aug 8, 20232023/Q2933.000K / 5.740M--
May 3, 20232023/Q158.980M / 33.529M--
Feb 28, 20232022/Q444.356M / 18.407M--
Nov 3, 20222022/Q314.981M / 15.486M--
Aug 3, 20222022/Q218.549M / 12.562M--
May 4, 20222022/Q118.414M / 9.011M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.273M--
--2024/Q1-- / 1.260M--
Feb 26, 20242023/Q41.676M / 1.528M--
Nov 8, 20232023/Q31.944M / 900.000K--
Aug 8, 20232023/Q2933.000K / 5.740M--
May 3, 20232023/Q158.980M / 33.529M--
Feb 28, 20232022/Q444.356M / 18.407M--
Nov 3, 20222022/Q314.981M / 15.486M--
Aug 3, 20222022/Q218.549M / 12.562M--
May 4, 20222022/Q118.414M / 9.011M--

Unlock Free Earnings Estimates

Fate Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 12, 2024

Hold

  • Buy

    26.67%
  • Hold

    66.67%
  • Sell

    6.67%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg